Clinical and Radiographic Evaluation of Vital Pulpotomy Techniques in Primary Molars Using of Premixed Bioactive Bioceramic MTA (Neo-putty) as a Novel Pulpotomy Medication Versus Formocresol: A Randomized Clinical Trial.
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Despite the benefit of formocresol, there are toxic effects allergic reactions and local soft and hard tissue necrosis have been reported when such formaldehyde compounds were used clinically, however, the adverse effect of the clinically used of this compound are not widely reported. It has been stated that it has a side effect on the permanent successor although it results as a successful technique for the treatment of the primary teeth
Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Maximum Age: 9
Healthy Volunteers: t
View:
• 4 -9 years old
• Primary molars with no spontaneous or provoked pain
• Primary molars with at least two-thirds of the root length were still present.
• Primary molars with no sign of internal or other kinds of root or bone resorption.
Locations
Other Locations
Egypt
MSA University
RECRUITING
El-sheikh Zayed City
Contact Information
Primary
Marwa A Salamon, Ph.D
maasalmon@msa.edu.eg
+20 101 655 5055
Backup
Marwa A Salmoon, Ph.D
maasalmoon@msa.edu.eg
01016555055
Time Frame
Start Date: 2024-03-20
Estimated Completion Date: 2025-02-01
Participants
Target number of participants: 44
Treatments
Active_comparator: full-strength FC
Formocresol pulpotomy is one of the most common procedure in cases of mechanical and carious exposure in primary teeth.
Experimental: Neo-Putty®
Neo-Putty® as dressing agents in pulpotomized primary molars. NeoPUTTY® is composed of extremely fine inorganic tricalcium/dicalcium silicate powders in a water-free organic liquid and contains tantalum oxide as the radiopacifying agent.
Related Therapeutic Areas
Sponsors
Leads: October University for Modern Sciences and Arts